Nueva Ecija opposes plan to turn drug rehab center into nCoV treatment facility | Inquirer News

Nueva Ecija opposes plan to turn drug rehab center into nCoV treatment facility

By: - Correspondent / @AMGalangINQ
/ 08:40 PM February 04, 2020

PALAYAN CITY–The provincial board of Nueva Ecija on Monday (Feb. 2) passed a resolution asking the Department of Health to reconsider its plan to turn the Drug Abuse Treatment and Rehabilitation Center in the province into a quarantine zone for nCoV patients.

Local officials said the resolution mirrored the sentiment of the people of Nueva Ecija who have expressed fear of and opposition to the plan.


Vice Gov. Antonio Umali said the resolution was their “polite expression” of opposition to the plan, recognizing that the facility was owned by the national government.

The provincial board members said they were apprehensive over the DOH’s plan since DATRC is near densely populated villages around Fort Magsaysay.


DATRC is being operated by the DOH inside the military camp.

Maj. Gen. Lenard Agustin, commander of the Army’s 7th Infantry Division, said the proposed 14-day quarantine of nCoV patients in the facility is a redundancy protocol set up as a precaution against the disease.

Edited by TSB

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: Coronavirus, DoH, Nueva Ecija, rehab, Virus
For feedback, complaints, or inquiries, contact us.

News that matters

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.

© Copyright 1997-2022 | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.